Elpida Therapeutics SPC
4 clinical trials · Sponsor
◉ Watch Elpida Therapeutics SPC
| Record | Firm | Date |
|---|---|---|
| Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) (NCT07447557) | Elpida Therapeutics SPC | 2026-07-01 |
| Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls. (NCT06692712) | Elpida Therapeutics SPC | 2026-04-01 |
| A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J (NCT06151600) | Elpida Therapeutics SPC | 2024-07-29 |
| Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) (NCT05518188) | Elpida Therapeutics SPC | 2023-02-15 |
Track Elpida Therapeutics SPC automatically
Every clearance here is in the API, with alerts when new ones post.